Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,556.37
(
-0.37%
)
US TECH 100
23,602.40
(
1.04%
)
Dow Jones
46,124.06
(
-0.18%
)
Brent Oil
95.83
(
-0.70%
)
Bitcoin
71,323.00
(
1.14%
)
News Focus
News Focus
Post# of 257275
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biotech jim

Send PM Follow Ignore
Followers 49
Posts 644
Boards Moderated 0
Alias Born 05/02/2011

biotech jim

Re: genisi post# 177186

Wednesday, 04/23/2014 11:31:39 AM

Wednesday, April 23, 2014 11:31:39 AM

Post# of 257275
Here are GILD's TAF (GS-7340) timelines:

2Q, 14 Complete enrollment for the 3 TAF studies (switch, renally impaired, adolescent, and Trt-experienced)

2Q, 14 Initiate Ph3, FTC/TAF vs FTF/Truvada

4Q, 14 Top line data from Ph3 Trt-naive

1Q, 15 Filing in Trt-naive, TRT-experienced, and switchers)

Comes from today's Equity Research report on GILD, high five to Doug for this!
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today